Ronyglim MP 1mg/500mg/15mg Tablet
By Ronyglim MP
Rx
10 Tablet in a Strip

Composition
Glimepiride(1mg) + Metformin(500mg) + Pioglitazone(15mg)

Manufacturer - Ronyd Healthcare Pvt Ltd
JMD Regent Arcade Shop no. 13-14, First Floor MG Road Gurgaon-122001 (INDIA)

Expires on or after
October, 2025

liver
When using Ronyglim MP 1mg/500mg/15mg Tablet, it is important to exercise caution if you have liver disease. Patients with liver issues may require a dose adjustment when taking Ronyglim MP 1mg/500mg/15mg Tablet. It is crucial to consult your doctor before using this medication, especially if you have any liver conditions. It is not advisable to use Ronyglim MP 1mg/500mg/15mg Tablet if you have severe liver disease. Always seek guidance from your healthcare provider regarding the use of this medication for your safety.

kidney
Caution Ronyglim MP 1mg/500mg/15mg Tablet may require dose adjustment for patients with kidney disease. Avoid use in severe kidney disease. Regular kidney function tests are recommended. Consult your doctor for proper guidance before using Ronyglim MP 1mg/500mg/15mg Tablet.

alcohol
It is not safe to drink alcohol while taking Ronyglim MP 1mg/500mg/15mg Tablet.

driving
If you experience low or high blood sugar, avoid driving while taking Ronyglim MP 1mg/500mg/15mg Tablet. Be cautious and refrain from driving if these symptoms occur.

pregnancy
Ronyglim MP 1mg/500mg/15mg Tablet may not be safe during pregnancy. Limited human studies indicate potential harm to the baby, as seen in animal studies. Consult your doctor to discuss benefits and risks.

breastfeeding
Caution is advised when breastfeeding while using Ronyglim MP 1mg/500mg/15mg Tablet as it may be unsafe. Limited data shows the drug could potentially pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹69.9
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024